On Wednesday, the US Drug Enforcement Administration (DEA) announced in the Federal Register that it is seeking to increase its marijuana production quota for the year 2015 by nearly three-fold.
Federal regulations permit a farm at the University of Mississippi to cultivate set quantities of cannabis for use in federally approved clinical trials. Regulators at the DEA, the US Food and Drug Administration, PHS (Public Health Service), and the US National Institute on Drug Abuse must approve any clinical protocol seeking to study the plant’s effects in human subjects.
The agency says that the increased production is necessary because "research and product development involving cannabidiol is increasing beyond that previously anticipated." The agency further acknowledged receiving increased requests from NIDA "to provide for ongoing and anticipated research efforts involving marijuana."
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org.